Market Capitalization

Onfolio Holdings is betting on a 1-for-50 reverse split to save its Nasdaq listing. But is it a lifeline or a red flag for a company facing deeper issues?

By wiping its balance sheet clean, Lode Gold signals its turnaround is complete. Now, the junior miner turns its focus to reviving a storied California mine.

With a unique process for pristine graphene, HydroGraph heads to an elite investor conference, signaling a pivotal shift from R&D to industrial scale.

A new government push and private sector players like AegisClear are building the digital rails for tokenization, aiming to transform Taiwan into a key Asian hub.

With revenue doubling and overseas sales exploding, APR's Q2 results aren't just good—they're a blueprint for how beauty tech is conquering the West.

The routine $0.25 dividend from MKS Inc. is no mere shareholder handout. It’s a calculated signal of financial discipline in a capital-hungry industry.

DDC Enterprise reports a 28% revenue surge, but the real story is how its food business funds an ambitious Bitcoin treasury and shareholder value strategy.

An AI-driven biodefense firm is using anti-racketeering laws to fight alleged market fraud. Is this a landmark battle for market integrity?

Newly-listed GoldInxs is wasting no time, using its $1.54M IPO to fund an advanced 3D survey on a BC property with 'Blackwater-style' potential.

The EdTech firm's demand-led move into AI compute is bold, but a complex financial picture and hardware risks create a high-wire act for investors.

IT solutions provider Hitek Global is betting big on digital marketing with its $20M acquisition. Is this a savvy pivot or a costly diversification?

Gaming giant Flutter Entertainment has abandoned the London Stock Exchange for New York. It's more than a listing change; it's a strategic realignment.

NewcelX secured a small but vital $1.4M financing at a 20% premium. It's a bold vote of confidence, but is it enough to outrun a 'going concern' warning?

Circle just secured a coveted New York trust charter, creating a 'state-federal compliance stack' for USDC. Here's why this is a game-changer.

Karyopharm's stock plummets after a key cancer trial fails, forcing a strategic retreat and a hard pivot toward more promising assets in its pipeline.

New patents in Europe and Australia grant Savara long-term protection for a vital new therapy, offering hope to patients with a rare, debilitating lung disease.

The sandwich giant's IPO isn't just about cashing in. It's a strategic move to fund global expansion and dominate a fiercely competitive fast-casual market.

Processa Pharmaceuticals acquires Vidya Therapeutics and its key asset, VT-7208, backed by a $200M financing that radically overhauls the company's strategy.

CleanCore Solutions signs a massive AI data center deal worth up to $3B, marking a high-stakes pivot from its eclectic past into the AI infrastructure gold rush.

Facing a harsh new Nasdaq rule, HCTI used legacy M&A deals to boost its market value, tying its survival to a strategic pivot toward AI and global expansion.